Abstract: 1234YL[Problem] To provide a compound useful as a pharmaceutical composition for prevention and/or treatment of diseases such as schizophrenia. [Solution] The inventors developed the present invention upon investigating a pharmaceutical composition having effects as a GABAB positive allosteric modulator (effects as a PAM) for preventing/treating diseases such as schizophrenia and confirming that a sulfur containing bicyclic compound has effects as a GABAB PAM. This sulfur containing bicyclic compound has effects as a GABAB PAM and can be used as a preventive and/or therapeutic agent for diseases such as schizophrenia. (In the formula X represents CH R represents a lower alkyl R represents a lower alkyl R represents H R represents H ring A is a cyclohexane ring R represents a group represented by formula (III) Y represents NH etc. and R represents a lower alkyl.)
soft copy attached in pdf
| # | Name | Date |
|---|---|---|
| 1 | Power of Attorney [15-04-2016(online)].pdf | 2016-04-15 |
| 2 | Form 5 [15-04-2016(online)].pdf | 2016-04-15 |
| 3 | Form 3 [15-04-2016(online)].pdf | 2016-04-15 |
| 4 | Form 1 [15-04-2016(online)].pdf | 2016-04-15 |
| 5 | Description(Complete) [15-04-2016(online)].pdf | 2016-04-15 |
| 6 | 201647013249.pdf | 2016-06-08 |
| 7 | 201647013249-OTHERS-040516.pdf | 2016-07-14 |
| 8 | 201647013249-Correspondence-Others-040516.pdf | 2016-07-14 |
| 9 | Other Patent Document [06-10-2016(online)].pdf | 2016-10-06 |
| 10 | Form 3 [06-10-2016(online)].pdf | 2016-10-06 |
| 11 | Form 3 [05-07-2017(online)].pdf | 2017-07-05 |
| 12 | 201647013249-RELEVANT DOCUMENTS [19-07-2017(online)].pdf | 2017-07-19 |
| 13 | 201647013249-MARKED COPIES OF AMENDEMENTS [19-07-2017(online)].pdf | 2017-07-19 |
| 14 | 201647013249-FORM 18 [19-07-2017(online)].pdf | 2017-07-19 |
| 15 | 201647013249-AMMENDED DOCUMENTS [19-07-2017(online)].pdf | 2017-07-19 |
| 16 | 201647013249-Amendment Of Application Before Grant - Form 13 [19-07-2017(online)].pdf | 2017-07-19 |
| 17 | 201647013249-FER.pdf | 2019-03-20 |
| 18 | 201647013249-PETITION UNDER RULE 137 [28-08-2019(online)].pdf | 2019-08-28 |
| 19 | 201647013249-OTHERS [28-08-2019(online)].pdf | 2019-08-28 |
| 20 | 201647013249-FORM 3 [28-08-2019(online)].pdf | 2019-08-28 |
| 21 | 201647013249-FER_SER_REPLY [28-08-2019(online)].pdf | 2019-08-28 |
| 22 | 201647013249-CLAIMS [28-08-2019(online)].pdf | 2019-08-28 |
| 23 | 201647013249-certified copy of translation (MANDATORY) [28-08-2019(online)].pdf | 2019-08-28 |
| 24 | 201647013249-ABSTRACT [28-08-2019(online)].pdf | 2019-08-28 |
| 25 | 201647013249-HearingNoticeLetter-(DateOfHearing-25-10-2019).pdf | 2019-10-03 |
| 26 | 201647013249-Correspondence to notify the Controller (Mandatory) [24-10-2019(online)].pdf | 2019-10-24 |
| 27 | 201647013249-Written submissions and relevant documents (MANDATORY) [08-11-2019(online)].pdf | 2019-11-08 |
| 28 | 201647013249-Retyped Pages under Rule 14(1) (MANDATORY) [08-11-2019(online)].pdf | 2019-11-08 |
| 29 | 201647013249-MARKED COPIES OF AMENDEMENTS [08-11-2019(online)].pdf | 2019-11-08 |
| 30 | 201647013249-FORM 3 [08-11-2019(online)].pdf | 2019-11-08 |
| 31 | 201647013249-FORM 13 [08-11-2019(online)].pdf | 2019-11-08 |
| 32 | 201647013249-2. Marked Copy under Rule 14(2) (MANDATORY) [08-11-2019(online)].pdf | 2019-11-08 |
| 33 | 201647013249_Marked up Claims_Granted 326882_06-12-2019.pdf | 2019-12-06 |
| 34 | 201647013249_Description_Granted 326882_06-12-2019.pdf | 2019-12-06 |
| 35 | 201647013249_Claims_Granted 326882_06-12-2019.pdf | 2019-12-06 |
| 36 | 201647013249_Abstract_Granted 326882_06-12-2019.pdf | 2019-12-06 |
| 37 | 201647013249-PatentCertificate06-12-2019.pdf | 2019-12-06 |
| 38 | 201647013249-IntimationOfGrant06-12-2019.pdf | 2019-12-06 |
| 39 | 201647013249-RELEVANT DOCUMENTS [17-02-2020(online)].pdf | 2020-02-17 |
| 40 | 201647013249-RELEVANT DOCUMENTS [09-08-2021(online)].pdf | 2021-08-09 |
| 41 | 201647013249-RELEVANT DOCUMENTS [28-09-2022(online)].pdf | 2022-09-28 |
| 42 | 201647013249-RELEVANT DOCUMENTS [21-09-2023(online)].pdf | 2023-09-21 |
| 1 | search_20-03-2019.pdf |
| 2 | 2019_0011_Transcript(1)_20-03-2019.pdf |